DEPOCYT

Serial Number 75505327
Registration 2390316
710

Registration Progress

Application Filed
Jun 19, 1998
Under Examination
Oct 26, 1999
Approved for Publication
Jul 2, 1999
Published for Opposition
Aug 3, 1999
Registered
Sep 26, 2000

Basic Information

Serial Number
75505327
Registration Number
2390316
Filing Date
June 19, 1998
Registration Date
September 26, 2000
Published for Opposition
August 3, 1999
Renewal Date
September 26, 2010
Cancellation Date
November 5, 2021
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Nov 5, 2021

Rights Holder

PACIRA PHARMACEUTICALS, INC.

03
Address
10450 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121

Ownership History

CHIRON CORP0RATION

Original Applicant
03
EMERYVILLE, CA

DEPOTECH CORPORATION

Original Applicant
03
SAN DIEGO, CA

DepoTech Corporation

Owner at Publication
03
San Diego, CA

Chiron Corporation

Owner at Publication
03
Emeryville, CA

SKYEPHARMA INC.

New Owner After Publication #1
03
SAN DIEGO, CA

CHIRON CORPORATION

New Owner After Publication #1
03
EMERYVILLE, CA

SKYEPHARMA INC.

Original Registrant
03
SAN DIEGO, CA

CHIRON CORPORATION

Original Registrant
03
EMERYVILLE, CA

SKYEPHARMA INC.

New Owner After Registration #1
03
SAN DIEGO, CA

PACIRA PHARMACEUTICALS, INC.

New Owner After Registration #2
03
SAN DIEGO, CA

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.
USPTO Deadlines 4 active 4 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEA May 07, 1999 9558 days overdue Low No
OPPOSITION
Notice of Publication
NPUB Aug 01, 1999 9472 days overdue Medium Until Sep 01, 1999
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Apr 26, 2000 9203 days overdue High Until Oct 26, 2000
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEA Jun 09, 2000 9159 days overdue Low No

Application History

35 events
Date Code Type Description
Nov 5, 2021 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 26, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 9, 2014 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 9, 2014 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 16, 2012 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 27, 2010 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 27, 2010 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 23, 2010 E89R I TEAS SECTION 8 & 9 RECEIVED
Jul 20, 2007 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2007 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 11, 2007 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 28, 2006 PLGL A ASSIGNED TO PARALEGAL
Nov 28, 2006 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 25, 2006 E815 I TEAS SECTION 8 & 15 RECEIVED
Sep 25, 2006 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Sep 22, 2006 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2006 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 14, 2006 CFIT O CASE FILE IN TICRS
Jun 20, 2005 MAIL I PAPER RECEIVED
Mar 1, 2002 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Dec 20, 2001 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Nov 17, 2000 AMD7 I SEC 7 REQUEST FILED
Sep 26, 2000 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 2, 2000 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 25, 2000 CNEA S EXAMINERS AMENDMENT -WRITTEN
May 4, 2000 DOCK D ASSIGNED TO EXAMINER
Apr 26, 2000 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 3, 2000 IUAF S USE AMENDMENT FILED
Oct 26, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 3, 1999 PUBO A PUBLISHED FOR OPPOSITION
Jul 2, 1999 NPUB O NOTICE OF PUBLICATION
Apr 26, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 1999 CNEA F EXAMINER'S AMENDMENT MAILED
Mar 16, 1999 CNRT F NON-FINAL ACTION MAILED
Feb 24, 1999 DOCK D ASSIGNED TO EXAMINER

Additional Information

Other
In the statement, Column 1, lines 1-7, should be deleted, and, "Chiron Corporation, (Delaware Corporation), 4560 Horton Street, Emeryville, CA 946082916" and "Skyepharma Inc., (California Corporation), 10450 Science Center Drive, San Diego, CA 92121, by change of name from" should be inserted.